Caverject (alprostadil) NDC 0009-3701

NDC codes

FDA NDC Directory

Product NDC (as listed)0009-3701Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00009-3701Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0009-3701-05	00009370105	6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3701-05) / 1 mL in 1 VIAL, SINGLE-DOSE (0009-3701-08)Marketed from Jul 6, 1995

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caverject
Generic name (nonproprietary): alprostadil
Active ingredients: Alprostadil — 20.5 ug/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intracavernous
Labeler: Pharmacia & Upjohn Company LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020379
Marketing start: Jul 6, 1995
Listing expires: Dec 31, 2026
Other FDA classes: Genitourinary Arterial Vasodilation (Physiologic effect)Prostaglandin Receptor Agonists (Mechanism)Prostaglandins (Chemical structure)Venous Vasodilation (Physiologic effect)
Identifiers: Product ID 0009-3701_c9c81920-1b63-4318-9cc1-38cc4d3fa601SPL ID c9c81920-1b63-4318-9cc1-38cc4d3fa601SPL set ID a295fc1e-d82c-4f44-bc2d-a552bf594c98RxCUI 103956, 226921, 226922, 242691UNII F5TD010360
Pharmacologic class: Prostaglandin Analog; Prostaglandin E1 Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400009370105 followed by a unit qualifier and the quantity

Package 00009-3701-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2024.

Indications (excerpt from the label)

CAVERJECT is a prostaglandin E1 agonist indicated • For the treatment of erectile dysfunction ( 1.1 ). • As an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction ( 1.2 ). 1.1 Erectile Dysfunction CAVERJECT is indicated for the treatment of erectile dysfunction. 1.2 Diagnostic Test CAVERJECT is indicated as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020379

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020379
Product	Strength	Form · route	Labeler	Product NDC
Caverjectalprostadil	Alprostadil 41.1 ug/mL	Injection, Powder, Lyophilized, For solutionIntracavernous	Pharmacia & Upjohn Company LLC	0009-7686